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Introduction. The neurobiology of drug
addiction: new vistas
This Royal Society Discussion Meeting, held on 25–26
February 2008, was intended to mark the enormous
scientiﬁc progress that has been made in this ﬁeld in the
last decade or so, advances that can be measured from
the time of a Frontiers Meeting of the Wellcome Trust
(Altman et al. 1996). At that time, it was already clear
that the nucleus accumbens in the ventral striatum of
the basal forebrain was a key structure mediating some
of the positive reinforcing (‘rewarding’) effects of
several drugs of abuse, especially the psychomotor
stimulant drugs, including cocaine and amphetamine.
The innervation of the nucleus accumbens by the
chemical neurotransmitter dopamine was also known
to be a key mediator of some of these actions. However,
although it was suspected that the nucleus accumbens
was merely one node in a complex circuitry at the
‘limbic–striatal interface’, the full nature and functions
of this circuitry were still unclear.
In parallel with these developments were new ideas
emanating from the realization that certain forms of
associative learning, including both Pavlovian and
instrumental conditioning, depended upon elements
of this system, for natural rewards such as food and sex,
as well as for drugs of abuse. It was already clear that
relapse derived in part from classical conditioning.
Some theorists had begun to speculate that certain
aspects of associative conditioning such as stimulus-
response habit learning were particularly relevant to
understanding drug abuse (e.g. White 1996), but the
modern theory of habit learning itself was still being
developed in a way that was to prove crucial for
understanding the functions of the striatum as a whole.
Dopamine had previously been related to ‘reward’
functions (see Wise 2004), but the shortcomings of this
bold, but simplistic, notion were already becoming
apparent, especially in relation to understanding how,
for example, opiate drugs exerted their addictive
actions. The concept of ‘opponent motivational
systems’, originally developed as a notable psycho-
logical theory, was just beginning to be related to
opponent neural systems, although the precise neural
correlates of the ‘negative’ component were still not
well understood. In addition to these basic issues of
neural mediation, the question of why only certain
individuals become addicted, even after exposure to
drugs of abuse, was only just being formulated, and the
consequences of drug addiction, including cognitive
impairment and possibly lack of self-control, were also
mainly a matter for speculation.
Many of these issues have been addressed in the ﬁrst
part of the Discussion Meeting, ‘Theories of Drug
Addiction’. Koob & Le Moal (2005), following on
from their synthesis, elaborate on the development of
their neural opponent motivational theory, which they
relate closely to the concepts of homeostasis and
allostasis from stress research, and which appears
especially relevant to the understanding of opiate
abuse. Central to this theory is the concept that
withdrawal leads to an aversive motivational state and
that much drug-seeking behaviour is directed towards
allieviating this state. Koob & Le Moal (2008) also
subscribe to a staging of addiction that includes an
initial ‘impulsivity’ phase followed by ‘compulsivity’,
which forms the central theme of the paper by Everitt
et al. (2008). These authors demonstrate how impul-
sive trait-like behaviour leads to compulsive-like
cocaine dependence, paralleling a ‘shift’ in the locus
of neural control from the ventral to the dorsal
striatum, and embracing a possible behavioural
transition in instrumental control to dominance
by stimulus–response habit-like representations.
Robinson & Berridge (2008) counterpoint these two
positions via their own ‘incentive salience’ hypothesis
with its focus on the sensitization by drugs of abuse of
the mesolimbic dopamine system. Finally, Stewart
(2008) reviews the considerable advances made in
delineating the distinct neural systems underlying
relapse, following exposure to stress, drug-related
cues or the drug itself.
Much of the advance in understanding of the
neurobiology of drug abuse has come from the study
of psychomotor stimulant and opiate drugs, but other
forms of addiction have been recognized, notably in the
case of nicotine, and now, more controversially, in the
form of the ‘behavioural addictions’ of gambling and
compulsive eating. The questions now being asked are
whether there are similar neural mechanisms under-
lying these extensions to the concept of addiction.
Hence, in the section entitled ‘Extending the Concept
of Addiction’, Markou (2008) illustrates the use of
applying similar concepts and methods to the under-
standing of nicotine addiction, as have been used for
the psychomotor stimulants. In particular, the advent
of drugs with glutamatergic or GABAergic actions is
shown to have implications for the treatment of
nicotine dependence. This is paralleled by Stephens &
Duka’s (2008) article on neural mechanisms under-
lying alcohol dependence, which shows how binge
drinking in humans can be modelled in rodents to
suggest important changes in glutamatergic mediated
excitability and reductions in neuronal plasticity (long-
term potentiation) in limbic structures such as the
amygdala and hippocampus. Potenza (2008) surveys
the burgeoning information concerning compulsive
gambling. Much of this concerns human behaviour and
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that have revealed a remarkable commonality of neural
systems mediating the reinforcing properties of drugs
and money. He also considers the comorbidity of
gambling with substance dependence (e.g. especially
alcoholism) and where similar issues of trait impulsivity
are seen as contributing to individual vulnerability to
gambling behaviour. Finally, the Director of the US
National Institute on Drug Abuse, Nora Volkow,
updates and extends her classic analysis (e.g. Volkow
et al.2 0 0 3 ) of neurochemical changes present in
substance abusers (using positron emission
tomography, PET) to include obese individuals and
animal models of obesity. These studies also raise the
issue of the possibly causal role of baseline individual
differences in striatal dopamine receptor binding that
are also taken up in the contributions by Everitt et al.
(2008) and Nader et al.( 2008; see below). She also
introduced an idea that has emerged from both the
animal (e.g. Jentsch & Taylor 1999; Robbins & Everitt
1999) and the human literature (Rogers & Robbins
2001) that substance abuse can arise from an
impairment of top-down inhibitory control, presum-
ably arising from impairments in frontal lobe function.
The next group of papers, ‘Vulnerability to drug
abuse’, appropriately consider genetic and environ-
mental factors contributing to the neurobiology of drug
abuse, especially in the vanguard of the Human
Genome Project. Crabbe (2008) focuses on the
contribution of behavioural genetics, mainly in the
mouse, to the understanding of alcoholism, where there
is perhaps the best evidence of heritability. He also
considers the likely importance of epigenetic factors.
Wong & Schumann (2008) introduce strategies addres-
singthe heterogeneity and polygenicityof substance use
based on the identiﬁcation of more homogeneous
subgroups of patients and the characterization of
genes contributing to their phenotype via linkage and
association studies. They also advocate functional
genetic analysis based on endophenotypes and animal
behavioural experimentation. By contrast, in work
parallel to that of Volkow et al. (2008), Nader et al.
(2008) present the results of an exceptionally systema-
tic series of PET studies of rhesus monkeys before and
after their exposure to cocaine. The crucial ﬁndings
were of reductions in striatal D2 dopamine receptor
binding being found before drug exposure, implying that
this change was not simply a consequence of drug
abuse, but may be predisposing to it. Everitt et al.
(2008) had also described the recent similar ﬁndings of
Dalley et al. (2007) for the rat, where reductions in D2
dopamine receptor binding had been associated with
enhanced impulsivity. Of course, the question arises
about the origin of such predisposing changes, whether,
for example, they depend on speciﬁc genes or are the
product of environmental factors. In the case of
the non-human primates, Nader et al. (2008) stress
the fact that the low dopamine receptor binding is asso-
ciated with likely stress resulting from social neglect.
Shaham and colleagues, in the paper by Crombag
etal.(2008),returntotheenvironmentalfactorsthrough
whichindividualsrelapsetosubstanceabuse,speciﬁcally
according to contextual conditioning. This article thus
complements the contribution by Stewart (2008) in
deﬁning the neural substrates of contextual reinstate-
ment of drug-seeking behaviour.
The ﬁnal section considers ‘Causes and Conse-
quences of Addiction’. Nestler (2008) begins by
reviewing the considerable advances over the last
decade in understanding of the intracellular molecular
changes associated with chronic exposure to drugs of
abuse, in particular biochemical changes in proteins
such as the transcription factor DFosB and its gene
targets. He is approaching this question by the use of
DNA expression arrays coupled with the analysis of
chromatin remodelling—changes in the posttransla-
tional modiﬁcations of histones at drug-regulated gene
promoters. His ﬁndings establish chromatin remodel-
ling as an important regulatory mechanism underlying
drug-induced behavioural plasticity, and promise to
reveal fundamentally new insight into how DFosB
contributes to addiction by regulating the expression of
speciﬁc target genes in brain reward pathways. The
paper by Porrino (Beveridge et al. 2008) surveys the
consequences of chronic drug exposure through self-
administration in monkeys that provide further evi-
dence for ramifying effects beyond the initial sites of
drug action in the ventral striatum to the dorsal
striatum and cortex, established by the methods
including autoradiography and the measurement of
cerebral metabolism in the temporal and frontal lobes.
These neuroanatomical changes are also accompanied
by impairments in cognitive function such as visual
recognition memory, which are also demonstrated to
occur in human drug abusers, using comparable
neuropsychological tests. Garavan et al. (2008) also
consider the sequelae of drug addiction in human
substance abusers from the vantage of functional brain
imaging using magnetic resonance. They provide
direct evidence that inhibitory control is impaired in
cocaine abusers, associated with altered activity of the
prefrontal cortex during performance of the stop signal
reaction time task. Moreover, they show surprisingly
that intravenous cocaine actually improves performance
in this task, not only in behavioural terms but also by
normalizing brain activity in lateral and medial regions
of the prefrontal cortex. These ﬁndings controversially
suggest that one possible factor contributing to the
susceptibility to stimulant addiction is a drive to self-
medication. The last contribution by O’Brien (2008)
focused speciﬁcally on treatment of addiction and
surveyed the large number of strategies that are
currently in vogue, particularly from a pharmaceutical
viewpoint. New treatments have emerged over the past
decade, manybased on the advances derivedfrom basic
neurobiology, and there are obvious indications for
opiate (e.g. buprenorphine), nicotine (e.g. patches)
and alcohol (e.g. acamprosate, naltrexone) abuse, as
well as more speculative candidate treatments such as
vaccination. However, drug companies still needed
encouragement to innovate in this area, and any
treatment for cocaine dependence is still problematic.
The discussion provoked by the meeting was a
measure of the contemporary interest in this ﬁeld from
the general public, as well as the scientiﬁc community.
Some of the current excitement has been engendered
in the UK by a Technology Foresight Initiative
in Brain Science, Addiction and Drugs,p u b l i s h e da s
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(Nutt et al.2 0 0 7 ). This initiative has recently been
the subject of a similarly named Academy of Medical
Sciences publication, containing recommendations
for the UK government for future policy in the ﬁeld
of drug addiction and related ﬁelds, such as the
treatment by drugs of mental illness and cognitive
enhancing drugs. The present Discussion Meeting has
helped to highlight the vibrancy of this ﬁeld in the UK
and internationally.
We thank Prof. L. L. Iversen for chairing one session and
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